Due to the significance of IFN in the host cell in restricting viral infections, particularly in the absence of an effective antiviral or vaccination strategy, IFN has been clinically approved (e.g., for the treatment of chronic hepatitis B or C). Here, IFNA1 is linked to chronic hepatitis B virus infection.